Position in REPL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,288,181
-$5,359,817 QoQ
Shares Held
929,375
-54.6% QoQ
Ownership
0.986%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 199 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,908,415,112 across 370 Biotechnology names. REPL ranks #159 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in REPL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,288,181 | 929,375 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $15,647,998 | 2,045,490 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $28,980,957 | 2,981,580 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,702,921 | 1,361,079 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,638,520 | 391,660 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,932,867 | 403,371 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $4,205,585 | 347,282 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,865,475 | 626,412 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $6,724,692 | 747,188 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,340,532 | 286,479 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,962,007 | 825,861 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $21,707,165 | 1,268,683 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $35,864,868 | 1,544,568 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $20,369,997 | 1,153,454 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $37,547,804 | 1,380,434 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,871,843 | 1,092,753 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $19,056,870 | 1,090,210 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $18,352,492 | 1,080,830 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $28,566,624 | 1,054,119 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $31,244,086 | 1,054,119 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $40,499,251 | 1,054,119 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $41,624,335 | 1,364,285 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $100,197,808 | 2,626,417 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $21,148,911 | 918,719 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $28,021,331 | 1,127,619 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $8,870,906 | 889,760 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||